Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.29 billion.
Market Cap
1.12T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.69B | -1.24% | 1,662,534 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.73B | -0.56% | 704,220 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.62B | -0.28% | 1,409,821 | 3.21B |
| 4 | ARGX | argenx SE | 49.38B | -0.89% | 458,060 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.53B | 3.35% | 5,365,505 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 37.39B | 5.47% | 660,815 | 4.97B |
| 7 | BNTX | BioNTech SE | 24.01B | 1.01% | 716,596 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.19B | -0.22% | 2,341,527 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.94B | 10.48% | 20,632,371 | - |
| 10 | INCY | Incyte Corporation | 20.98B | 0.90% | 1,506,016 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.92B | 1.87% | 1,506,163 | 3.85B |
| 12 | ROIV | Roivant Sciences Ltd. | 15.29B | 0.92% | 5,165,362 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 15.18B | 4.51% | 2,800,053 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.89B | 4.65% | 2,846,572 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 13.40B | 1.30% | 7,435,862 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.01B | -1.52% | 2,566,510 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.46B | -2.76% | 839,946 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.86B | -0.25% | 2,792,763 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.68B | -7.58% | 685,221 | 740.64M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | -2.32% | 2,387,394 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | - | 1,109,727 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.24B | 1.73% | 2,434,879 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.79B | 0.55% | 1,212,285 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.96B | -0.94% | 1,694,785 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.77B | -0.68% | 2,296,450 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.54B | 1.09% | 776,804 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.52B | 0.47% | 1,932,157 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 8.16B | 2.32% | 485,873 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 8.04B | 0.92% | 1,932,513 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.64B | -1.28% | 2,403,214 | 87.21M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.58B | 5.02% | 344,356 | 373.16M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.21B | -2.01% | 682,683 | 7.46M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.74B | 3.65% | 779,937 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.22B | 0.88% | 1,556,282 | 1.78B |
| 35 | PCVX | Vaxcyte, Inc. | 6.03B | 1.61% | 779,762 | - |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.98B | -0.28% | 582,142 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 5.94B | -3.44% | 334,459 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.46B | 0.02% | 2,195,704 | 1.54M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.38B | -0.62% | 2,201,407 | - |
| 40 | IMVT | Immunovant, Inc. | 5.28B | -1.06% | 1,579,077 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.26B | 0.66% | 800,101 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.13B | -4.54% | 2,053,155 | 38.34M |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.02B | 0.02% | 975,454 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.97B | 2.71% | 529,784 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.74B | 2.43% | 1,104,331 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | -0.48% | 751,076 | 1.05B |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.47B | 6.09% | 881,664 | 471.79M |
| 48 | FOLD | Amicus Therapeutics, Inc. | 4.42B | - | 10,481,963 | 598.70M |
| 49 | CGON | CG Oncology, Inc. | 4.37B | 29.26% | 6,905,048 | 2.17M |
| 50 | LEGN | Legend Biotech Corporation | 4.36B | 2.48% | 4,314,422 | 909.05M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.30B | 1.22% | 939,780 | - |
| 52 | ADMA | ADMA Biologics, Inc. | 4.27B | -0.66% | 2,137,699 | 488.56M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.16B | -6.66% | 3,191,553 | 531.90M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.07B | 3.23% | 183,986 | 251.23M |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.94B | 2.66% | 1,574,399 | 741.17M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.90B | -3.99% | 914,921 | 35.24M |
| 57 | TERN | Terns Pharmaceuticals, Inc. | 3.86B | -6.06% | 3,459,734 | - |
| 58 | ACLX | Arcellx, Inc. | 3.83B | 3.05% | 1,015,501 | 35.90M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.62B | 1.07% | 2,843,822 | - |
| 60 | VERA | Vera Therapeutics, Inc. | 3.46B | 2.14% | 803,057 | - |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | -5.56% | 1,704,303 | 317.93M |
| 62 | APLS | Apellis Pharmaceuticals, Inc. | 3.45B | 3.96% | 3,966,323 | 1.02B |
| 63 | IDYA | IDEAYA Biosciences, Inc. | 3.28B | 2.55% | 1,254,330 | 214.83M |
| 64 | CNTA | Centessa Pharmaceuticals plc | 3.28B | 1.68% | 1,126,127 | 15.00M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | -1.71% | 442,816 | 366.10M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.26B | 2.26% | 1,977,485 | 7.50M |
| 67 | LQDA | Liquidia Corporation | 3.12B | 12.91% | 7,893,853 | 69.22M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.09B | -2.87% | 2,843,241 | 435.83M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.03B | 4.62% | 1,670,919 | 70.79M |
| 70 | IRON | Disc Medicine, Inc. | 2.95B | -1.45% | 247,086 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.93B | -2.68% | 1,299,046 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.79B | 0.53% | 1,354,055 | 578.20M |
| 73 | NUVB | Nuvation Bio Inc. | 2.76B | -4.85% | 5,701,311 | 26.75M |
| 74 | BEAM | Beam Therapeutics Inc. | 2.72B | -1.61% | 1,154,255 | 55.70M |
| 75 | DNLI | Denali Therapeutics Inc. | 2.67B | 0.06% | 981,137 | - |
| 76 | MLYS | Mineralys Therapeutics, Inc. | 2.64B | 0.72% | 1,352,131 | - |
| 77 | EWTX | Edgewise Therapeutics, Inc. | 2.64B | -0.28% | 809,696 | - |
| 78 | MESO | Mesoblast Limited | 2.63B | 5.49% | 306,911 | 17.20M |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.60B | -1.59% | 2,378,789 | 240.00M |
| 80 | AAPG | Ascentage Pharma Group International | 2.59B | 3.19% | 1,436 | 54.52M |
| 81 | TLX | Telix Pharmaceuticals Limited | 2.54B | -0.92% | 98,012 | 664.23M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.53B | -6.68% | 3,648,164 | 109.23M |
| 83 | SRPT | Sarepta Therapeutics, Inc. | 2.50B | 2.94% | 1,975,277 | 2.41B |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.43B | -0.85% | 15,108,066 | 43.69M |
| 85 | NBY | NovaBay Pharmaceuticals, Inc. | 2.41B | 102.54% | 10,336,427 | 10.30M |
| 86 | ADPT | Adaptive Biotechnologies Corporation | 2.41B | -1.16% | 2,440,851 | 252.75M |
| 87 | OCUL | Ocular Therapeutix, Inc. | 2.40B | -1.05% | 2,614,697 | 55.78M |
| 88 | SYRE | Spyre Therapeutics, Inc. | 2.38B | 1.56% | 450,653 | - |
| 89 | IMNM | Immunome, Inc. | 2.32B | 3.03% | 2,815,557 | 9.68M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.31B | -5.49% | 1,806,933 | 98.68M |
| 91 | IBRX | ImmunityBio, Inc. | 2.29B | 4.02% | 12,382,666 | 82.56M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | 1.80% | 730,807 | 825.94M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.21B | 9.82% | 2,486,664 | - |
| 94 | GLPG | Galapagos NV | 2.17B | 0.36% | 96,492 | 336.64M |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | -3.02% | 2,724,637 | 630.60M |
| 96 | ZLAB | Zai Lab Limited | 2.06B | 0.27% | 689,378 | 441.63M |
| 97 | ALMS | Alumis Inc. | 2.04B | 7.59% | 5,947,990 | 22.12M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.17% | 1,205,224 | 265.81M |
| 99 | NRIX | Nurix Therapeutics, Inc. | 1.96B | 3.60% | 1,388,431 | 83.69M |
| 100 | VCEL | Vericel Corporation | 1.95B | -5.33% | 781,138 | 258.72M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.94B | 3.52% | 191,838 | 2.50M |
| 102 | ERAS | Erasca, Inc. | 1.92B | 16.35% | 11,399,088 | - |
| 103 | ARDX | Ardelyx, Inc. | 1.88B | 10.57% | 17,699,632 | 398.23M |
| 104 | STOK | Stoke Therapeutics, Inc. | 1.88B | -2.46% | 667,607 | 205.63M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -1.82% | 1,025,497 | 111.30M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.82B | 0.11% | 538,448 | 2.60M |
| 107 | MNKD | MannKind Corporation | 1.80B | -2.66% | 2,566,028 | 313.79M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.75B | 7.24% | 412,224 | - |
| 109 | ZYME | Zymeworks Inc. | 1.73B | 0.30% | 970,984 | 134.48M |
| 110 | KOD | Kodiak Sciences Inc. | 1.72B | 4.13% | 735,311 | - |
| 111 | PHVS | Pharvaris N.V. | 1.69B | 3.88% | 288,685 | - |
| 112 | IMCR | Immunocore Holdings plc | 1.67B | -0.15% | 320,612 | 379.59M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.89% | 1,163,047 | 44.79M |
| 114 | DNTH | Dianthus Therapeutics, Inc. | 1.64B | 0.18% | 912,716 | 3.08M |
| 115 | PGEN | Precigen, Inc. | 1.62B | -0.43% | 3,488,366 | 6.31M |
| 116 | UPB | Upstream Bio, Inc. | 1.61B | 8.02% | 843,062 | 2.80M |
| 117 | FTRE | Fortrea Holdings Inc. | 1.61B | -0.29% | 1,727,492 | 2.76B |
| 118 | TNGX | Tango Therapeutics, Inc. | 1.58B | 6.24% | 5,354,667 | 66.50M |
| 119 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -4.07% | 5,582,507 | 181.54M |
| 120 | QURE | uniQure N.V. | 1.58B | 9.37% | 4,585,178 | 15.75M |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.56B | -3.43% | 540,688 | - |
| 122 | ELVN | Enliven Therapeutics, Inc. | 1.54B | 11.83% | 5,665,918 | - |
| 123 | BHVN | Biohaven Ltd. | 1.47B | -2.20% | 2,814,853 | - |
| 124 | INVA | Innoviva, Inc. | 1.46B | -0.36% | 520,496 | 388.52M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.43B | -0.27% | 1,266,380 | - |
| 126 | MBX | MBX Biosciences, Inc. | 1.42B | 3.06% | 412,142 | - |
| 127 | SVRA | Savara Inc. | 1.40B | 0.95% | 1,098,835 | - |
| 128 | RLAY | Relay Therapeutics, Inc. | 1.38B | -0.12% | 1,111,664 | 8.36M |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.38B | 2.30% | 287,067 | - |
| 130 | TSHA | Taysha Gene Therapies, Inc. | 1.36B | -3.11% | 2,973,829 | 6.31M |
| 131 | MNMD | Mind Medicine (MindMed) Inc. | 1.36B | -5.85% | 2,042,166 | - |
| 132 | ATAI | AtaiBeckley Inc. | 1.36B | -5.54% | 4,846,491 | 3.02M |
| 133 | ORKA | Oruka Therapeutics, Inc. | 1.35B | 5.53% | 529,537 | - |
| 134 | EYPT | EyePoint, Inc. | 1.34B | -4.98% | 863,677 | 42.34M |
| 135 | OCS | Oculis Holding AG | 1.33B | 4.72% | 449,630 | 992.00K |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.32B | 28.94% | 14,270,627 | - |
| 137 | XERS | Xeris Biopharma Holdings, Inc. | 1.32B | -2.46% | 2,708,386 | 266.14M |
| 138 | ABCL | AbCellera Biologics Inc. | 1.31B | 6.33% | 6,414,719 | 35.33M |
| 139 | SPRY | ARS Pharmaceuticals, Inc. | 1.29B | 19.27% | 5,901,128 | 142.77M |
| 140 | PHAR | Pharming Group N.V. | 1.28B | 4.58% | 24,748 | 362.27M |
| 141 | ANAB | AnaptysBio, Inc. | 1.24B | 1.99% | 527,697 | 169.47M |
| 142 | CAPR | Capricor Therapeutics, Inc. | 1.23B | -6.69% | 2,560,198 | 11.13M |
| 143 | IMTX | Immatics N.V. | 1.23B | -1.61% | 411,316 | 99.45M |
| 144 | SANA | Sana Biotechnology, Inc. | 1.21B | 0.88% | 2,542,940 | - |
| 145 | NTLA | Intellia Therapeutics, Inc. | 1.20B | -1.33% | 6,697,449 | 57.53M |
| 146 | NVAX | Novavax, Inc. | 1.18B | -0.95% | 2,735,691 | 1.06B |
| 147 | AKTS | Aktis Oncology, Inc. | 1.18B | 24.44% | 2,985,308 | 5.56M |
| 148 | SEPN | Septerna, Inc. | 1.13B | -1.71% | 232,322 | 22.05M |
| 149 | PVLA | Palvella Therapeutics, Inc. | 1.09B | -5.10% | 224,984 | - |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | -3.75% | 1,519,998 | 147.19M |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.06B | -3.11% | 118,362 | 1.40M |
| 152 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.06B | -0.83% | 783,557 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.00B | 2.08% | 992,720 | 192.44M |
| 154 | NBTX | Nanobiotix S.A. | 999.43M | 2.85% | 43,016 | 11.93M |
| 155 | URGN | UroGen Pharma Ltd. | 994.69M | -9.46% | 843,431 | 96.52M |
| 156 | XNCR | Xencor, Inc. | 991.89M | -2.11% | 1,376,620 | 150.13M |
| 157 | VTYX | Ventyx Biosciences, Inc. | 985.46M | -0.22% | 11,902,168 | - |
| 158 | BCAX | Bicara Therapeutics Inc. | 983.34M | 8.39% | 395,392 | - |
| 159 | IOVA | Iovance Biotherapeutics, Inc. | 972.57M | -6.13% | 9,677,185 | 250.43M |
| 160 | TBPH | Theravance Biopharma, Inc. | 964.80M | 0.17% | 234,698 | 80.33M |
| 161 | CMPX | Compass Therapeutics, Inc. | 951.56M | 3.48% | 3,928,829 | 850.00K |
| 162 | RAPT | RAPT Therapeutics, Inc. | 931.64M | 7.76% | 320,718 | - |
| 163 | GHRS | GH Research PLC | 931.06M | -3.47% | 432,252 | - |
| 164 | DAWN | Day One Biopharmaceuticals, Inc. | 917.92M | -3.35% | 1,211,628 | 133.67M |
| 165 | IVA | Inventiva S.A. | 909.94M | -1.83% | 162,655 | 19.93M |
| 166 | MDXG | MiMedx Group, Inc. | 903.42M | -3.33% | 1,096,188 | 393.44M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 891.11M | 8.28% | 1,556,607 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 888.54M | -0.65% | 894,438 | 14.61M |
| 169 | OMER | Omeros Corporation | 885.55M | -7.14% | 4,483,479 | - |
| 170 | YDES | YD Bio Limited | 867.75M | 0.08% | 45,510 | 510.36K |
| 171 | ZBIO | Zenas BioPharma, Inc. | 863.16M | -2.01% | 522,795 | 15.00M |
| 172 | GERN | Geron Corporation | 855.40M | -2.19% | 15,548,371 | 183.40M |
| 173 | VALN | Valneva SE | 855.26M | 1.23% | 7,426 | 211.09M |
| 174 | JANX | Janux Therapeutics, Inc. | 851.69M | 1.80% | 1,221,227 | 10.00M |
| 175 | KALV | KalVista Pharmaceuticals, Inc. | 849.18M | 6.19% | 4,992,536 | 1.43M |
| 176 | AVBP | ArriVent BioPharma, Inc. | 847.09M | 4.59% | 300,073 | - |
| 177 | KURA | Kura Oncology, Inc. | 818.83M | -1.47% | 1,636,678 | 104.03M |
| 178 | VIR | Vir Biotechnology, Inc. | 813.88M | -1.68% | 1,308,497 | 16.86M |
| 179 | NKTR | Nektar Therapeutics | 807.76M | -4.17% | 722,930 | 62.60M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 786.42M | 4.83% | 131,243 | - |
| 181 | ANNX | Annexon, Inc. | 782.54M | -0.76% | 1,855,572 | - |
| 182 | ARVN | Arvinas, Inc. | 775.19M | -0.90% | 482,775 | 312.30M |
| 183 | LXEO | Lexeo Therapeutics, Inc. | 769.29M | 11.30% | 1,647,101 | - |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 741.30M | -8.22% | 679,555 | 282.08M |
| 185 | RGNX | REGENXBIO Inc. | 738.59M | -2.73% | 445,928 | 161.32M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 737.04M | 2.11% | 1,983,503 | 113.63M |
| 187 | ATXS | Astria Therapeutics, Inc. | 735.25M | -0.77% | 585,387 | 706.00K |
| 188 | DBVT | DBV Technologies S.A. | 705.91M | 0.06% | 247,915 | 5.50M |
| 189 | PROK | ProKidney Corp. | 703.95M | -0.85% | 817,565 | 744.00K |
| 190 | IVVD | Invivyd, Inc. | 698.35M | 0.40% | 3,220,118 | 50.04M |
| 191 | PRME | Prime Medicine, Inc. | 697.53M | 0.51% | 2,224,041 | 5.98M |
| 192 | DRUG | Bright Minds Biosciences Inc. | 687.66M | -3.62% | 176,973 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 672.59M | -2.25% | 48,180 | 107.27M |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 649.81M | -2.57% | 726,561 | 80.00M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 643.93M | -2.15% | 742,232 | - |
| 196 | EVMN | Evommune, Inc. | 634.58M | 10.42% | 510,449 | 13.00M |
| 197 | REPL | Replimune Group, Inc. | 629.90M | -2.43% | 1,138,108 | - |
| 198 | JBIO | Jade Biosciences, Inc. | 622.44M | 2.11% | 185,369 | - |
| 199 | VSTM | Verastem, Inc. | 601.25M | -1.02% | 2,025,690 | 13.38M |
| 200 | CRMD | CorMedix Inc. | 601.16M | 1.60% | 8,210,950 | 214.30M |
| 201 | MGTX | MeiraGTx Holdings plc | 596.44M | 1.79% | 465,808 | 27.42M |
| 202 | DRTS | Alpha Tau Medical Ltd. | 590.88M | 8.11% | 598,858 | - |
| 203 | ENGN | enGene Holdings Inc. | 590.13M | 3.65% | 434,375 | - |
| 204 | KROS | Keros Therapeutics, Inc. | 584.95M | 3.34% | 454,846 | 246.72M |
| 205 | GOSS | Gossamer Bio, Inc. | 578.64M | - | 3,353,448 | 44.05M |
| 206 | TENX | Tenax Therapeutics, Inc. | 539.59M | 1.37% | 298,263 | - |
| 207 | DSGN | Design Therapeutics, Inc. | 534.89M | 2.29% | 165,669 | - |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 525.17M | 1.99% | 708,387 | 180.61M |
| 209 | LBRX | LB Pharmaceuticals Inc | 524.45M | -0.34% | 222,216 | - |
| 210 | VOR | Vor Biopharma Inc. | 523.50M | 5.79% | 972,421 | - |
| 211 | NAGE | Niagen Bioscience, Inc. | 522.18M | -0.61% | 920,891 | 124.71M |
| 212 | LYEL | Lyell Immunopharma, Inc. | 521.54M | 1.03% | 109,796 | 41.00K |
| 213 | ANRO | Alto Neuroscience, Inc. | 508.56M | 3.02% | 210,430 | - |
| 214 | CRVS | Corvus Pharmaceuticals, Inc. | 507.09M | -1.88% | 1,617,784 | - |
| 215 | ASMB | Assembly Biosciences, Inc. | 502.04M | 0.57% | 109,984 | 37.19M |
| 216 | ABSI | Absci Corporation | 501.49M | -3.05% | 7,535,133 | 2.82M |
| 217 | PRTA | Prothena Corporation plc | 494.70M | 1.55% | 399,397 | 11.79M |
| 218 | SLS | SELLAS Life Sciences Group, Inc. | 492.85M | -10.36% | 17,303,701 | - |
| 219 | AUTL | Autolus Therapeutics plc | 481.72M | -5.24% | 2,051,386 | 51.13M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 477.97M | -1.62% | 746,088 | 84.39M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 475.32M | -1.54% | 576,861 | - |
| 222 | OCGN | Ocugen, Inc. | 468.48M | 0.67% | 2,804,463 | 5.37M |
| 223 | LENZ | LENZ Therapeutics, Inc. | 465.28M | -2.43% | 1,661,230 | 17.50M |
| 224 | BCYC | Bicycle Therapeutics plc | 461.35M | 0.31% | 161,960 | 28.34M |
| 225 | ADCT | ADC Therapeutics SA | 453.39M | 2.52% | 632,985 | 75.21M |
| 226 | PEPG | PepGen Inc. | 444.80M | -4.01% | 452,704 | - |
| 227 | VTVT | vTv Therapeutics Inc. | 441.45M | -13.36% | 29,942 | 17.00K |
| 228 | ALT | Altimmune, Inc. | 438.80M | -1.47% | 3,020,436 | 20.00K |
| 229 | DMAC | DiaMedica Therapeutics Inc. | 437.20M | -2.28% | 134,628 | - |
| 230 | VNDA | Vanda Pharmaceuticals Inc. | 433.18M | -0.14% | 1,239,818 | 212.07M |
| 231 | FDMT | 4D Molecular Therapeutics, Inc. | 428.51M | 2.74% | 626,364 | 120.00K |
| 232 | IMMP | Immutep Limited | 428.12M | -1.01% | 82,317 | 3.31M |
| 233 | NBP | NovaBridge Biosciences | 426.58M | -2.37% | 1,040,204 | - |
| 234 | FBRX | Forte Biosciences, Inc. | 425.81M | -1.24% | 258,438 | - |
| 235 | LXRX | Lexicon Pharmaceuticals, Inc. | 425.18M | -0.85% | 1,183,566 | 70.86M |
| 236 | MNPR | Monopar Therapeutics Inc. | 421.00M | -0.63% | 319,374 | - |
| 237 | PRTC | PureTech Health plc | 418.60M | 0.11% | 964 | 6.39M |
| 238 | LCTX | Lineage Cell Therapeutics, Inc. | 414.38M | -2.84% | 978,167 | 10.82M |
| 239 | SLDB | Solid Biosciences Inc. | 412.15M | -0.38% | 649,856 | - |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.41M | -5.47% | 234,760 | - |
| 241 | RCKT | Rocket Pharmaceuticals, Inc. | 403.67M | -3.87% | 1,445,003 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 400.93M | -2.79% | 93,259 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 384.81M | -4.17% | 413,381 | - |
| 244 | ALLO | Allogene Therapeutics, Inc. | 384.29M | 14.77% | 12,008,524 | 22.00K |
| 245 | AVXL | Anavex Life Sciences Corp. | 382.41M | 0.23% | 1,470,270 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 378.39M | -2.38% | 210,630 | 65.32M |
| 247 | NMRA | Neumora Therapeutics, Inc. | 377.26M | -4.72% | 2,145,471 | - |
| 248 | HELP | Cybin Inc. | 375.77M | 2.17% | 564,813 | - |
| 249 | XOMA | XOMA Royalty Corporation | 369.64M | -0.23% | 854,437 | 47.11M |
| 250 | TRDA | Entrada Therapeutics, Inc. | 359.33M | -4.75% | 99,145 | 61.52M |
| 251 | GLSI | Greenwich LifeSciences, Inc. | 350.24M | 12.81% | 527,037 | - |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 349.75M | -0.99% | 1,084,220 | 33.98M |
| 253 | CTNM | Contineum Therapeutics, Inc. | 340.09M | 1.42% | 233,567 | - |
| 254 | ACIU | AC Immune SA | 337.40M | -0.87% | 356,861 | 5.48M |
| 255 | ZURA | Zura Bio Limited | 332.92M | -2.66% | 268,792 | - |
| 256 | CLLS | Cellectis S.A. | 324.74M | -1.56% | 31,710 | 82.55M |
| 257 | AURA | Aura Biosciences, Inc. | 323.23M | -1.36% | 174,199 | - |
| 258 | RLMD | Relmada Therapeutics, Inc. | 316.07M | -2.71% | 278,830 | - |
| 259 | CADL | Candel Therapeutics, Inc. | 313.47M | 2.88% | 659,553 | - |
| 260 | AARD | Aardvark Therapeutics, Inc. | 310.70M | -1.65% | 105,451 | - |
| 261 | TARA | Protara Therapeutics, Inc. | 308.13M | 2.50% | 648,589 | - |
| 262 | PBYI | Puma Biotechnology, Inc. | 307.89M | -1.45% | 322,084 | 212.00M |
| 263 | CAMP | Camp4 Therapeutics Corporation | 307.66M | -4.35% | 208,832 | 3.80M |
| 264 | AVTX | Avalo Therapeutics, Inc. | 307.37M | -0.94% | 174,131 | 192.00K |
| 265 | STTK | Shattuck Labs, Inc. | 300.58M | 2.37% | 1,741,916 | 1.00M |
| 266 | IMRX | Immuneering Corporation | 300.57M | -1.59% | 4,851,796 | - |
| 267 | PALI | Palisade Bio, Inc. | 296.52M | 4.74% | 5,842,542 | - |
| 268 | ACHV | Achieve Life Sciences, Inc. | 295.98M | 1.65% | 854,572 | - |
| 269 | MENS | Jyong Biotech Ltd. | 292.99M | -4.75% | 255,609 | - |
| 270 | FHTX | Foghorn Therapeutics Inc. | 291.80M | -1.34% | 164,488 | 24.52M |
| 271 | ACRS | Aclaris Therapeutics, Inc. | 286.03M | -1.49% | 489,643 | 15.74M |
| 272 | LRMR | Larimar Therapeutics, Inc. | 285.02M | -0.89% | 725,236 | - |
| 273 | ABEO | Abeona Therapeutics Inc. | 281.25M | 1.96% | 1,348,330 | 400.00K |
| 274 | NGNE | Neurogene Inc. | 277.58M | -4.07% | 96,195 | 925.00K |
| 275 | OABI | OmniAb, Inc. | 274.95M | 1.06% | 232,922 | 21.09M |
| 276 | GUTS | Fractyl Health, Inc. | 274.09M | -4.76% | 2,697,905 | 3.00K |
| 277 | OBIO | Orchestra BioMed Holdings, Inc. | 271.03M | -0.83% | 274,395 | 2.82M |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 269.54M | -4.43% | 310,725 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 265.37M | 2.51% | 140,813 | 38.79M |
| 280 | SLN | Silence Therapeutics plc | 260.73M | -4.83% | 297,662 | 25.83M |
| 281 | NAUT | Nautilus Biotechnology, Inc. | 260.19M | -7.21% | 345,412 | - |
| 282 | ARMP | Armata Pharmaceuticals, Inc. | 256.67M | -10.65% | 58,383 | 5.05M |
| 283 | IMMX | Immix Biopharma, Inc. | 256.63M | -4.32% | 1,128,652 | - |
| 284 | HRTX | Heron Therapeutics, Inc. | 254.87M | 9.45% | 7,291,617 | 155.10M |
| 285 | ALDX | Aldeyra Therapeutics, Inc. | 247.27M | -1.67% | 636,821 | - |
| 286 | RZLT | Rezolute, Inc. | 243.87M | 10.97% | 5,834,606 | - |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 242.17M | 31.69% | 12,321,266 | 26.87M |
| 288 | CLYM | Climb Bio, Inc. | 240.15M | 9.83% | 1,405,668 | - |
| 289 | MDWD | MediWound Ltd. | 239.76M | -3.11% | 70,561 | 20.93M |
| 290 | IKT | Inhibikase Therapeutics, Inc. | 234.58M | 2.69% | 627,086 | 1.00 |
| 291 | HUMA | Humacyte, Inc. | 225.81M | - | 2,731,766 | 1.57M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 223.51M | -0.99% | 358,119 | 31.32M |
| 293 | OVID | Ovid Therapeutics Inc. | 217.41M | -3.47% | 940,057 | 6.61M |
| 294 | PRLD | Prelude Therapeutics Incorporated | 216.71M | -4.71% | 622,047 | 10.50M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 216.70M | -4.41% | 86,518 | - |
| 296 | ENLV | Enlivex Therapeutics Ltd. | 214.05M | 7.61% | 421,165 | - |
| 297 | RNAC | Cartesian Therapeutics, Inc. | 213.23M | 0.99% | 270,678 | 1.09M |
| 298 | CBIO | Crescent Biopharma, Inc. | 210.94M | -1.64% | 74,858 | - |
| 299 | CRDF | Cardiff Oncology, Inc. | 207.47M | -2.84% | 1,040,080 | 501.00K |
| 300 | CCCC | C4 Therapeutics, Inc. | 207.40M | -2.28% | 1,080,700 | 30.11M |
| 301 | MIST | Milestone Pharmaceuticals Inc. | 207.23M | -6.85% | 6,160,590 | - |
| 302 | CHRS | Coherus Oncology, Inc. | 204.27M | 10.46% | 3,717,004 | 277.73M |
| 303 | GALT | Galectin Therapeutics Inc. | 203.09M | -1.56% | 670,202 | - |
| 304 | ALEC | Alector, Inc. | 203.02M | 5.08% | 1,302,901 | 69.05M |
| 305 | CABA | Cabaletta Bio, Inc. | 202.16M | -3.23% | 1,293,604 | - |
| 306 | EDIT | Editas Medicine, Inc. | 202.07M | -3.27% | 1,060,542 | 46.38M |
| 307 | SGMT | Sagimet Biosciences Inc. | 201.96M | 11.49% | 2,088,405 | - |
| 308 | NTHI | NeOnc Technologies Holdings, Inc. | 194.74M | 1.73% | 71,930 | 59.99K |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.65M | 0.15% | 347,814 | 97.60M |
| 310 | NERV | Minerva Neurosciences, Inc. | 192.57M | -5.32% | 51,707 | - |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.82M | 2.04% | 215,879 | 10.30M |
| 312 | PRQR | ProQR Therapeutics N.V. | 186.46M | -15.71% | 1,285,788 | 18.86M |
| 313 | KLRS | Kalaris Therapeutics, Inc. | 182.91M | 18.40% | 229,892 | - |
| 314 | CGEN | Compugen Ltd. | 175.85M | 14.63% | 1,294,474 | 6.90M |
| 315 | SABS | SAB Biotherapeutics, Inc. | 175.19M | -4.66% | 385,979 | 114.70K |
| 316 | RANI | Rani Therapeutics Holdings, Inc. | 170.13M | 0.72% | 898,025 | 1.20M |
| 317 | TLSA | Tiziana Life Sciences Ltd | 169.92M | -3.38% | 283,369 | - |
| 318 | IPSC | Century Therapeutics, Inc. | 169.39M | 9.60% | 2,291,779 | 113.34M |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 166.47M | 3.50% | 1,545,684 | 61.84M |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 165.54M | -0.96% | 3,083,187 | - |
| 321 | IPHA | Innate Pharma S.A. | 163.41M | 3.85% | 10,580 | 14.84M |
| 322 | SLGL | Sol-Gel Technologies Ltd. | 163.11M | 5.15% | 14,471 | 18.97M |
| 323 | BDTX | Black Diamond Therapeutics, Inc. | 160.10M | 1.08% | 1,173,799 | 70.00M |
| 324 | VXRT | Vaxart, Inc. | 159.01M | 38.07% | - | 148.20M |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 158.93M | 6.24% | 884,250 | 142.53M |
| 326 | SRZN | Surrozen, Inc. | 158.49M | -2.99% | 79,958 | 3.60M |
| 327 | CRBU | Caribou Biosciences, Inc. | 155.16M | -1.78% | 701,507 | 9.30M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.97M | -0.60% | 178,456 | - |
| 329 | MOLN | Molecular Partners AG | 153.73M | -3.53% | 2,682 | 856.30K |
| 330 | QNCX | Quince Therapeutics, Inc. | 149.78M | 0.37% | 608,391 | - |
| 331 | SGMO | Sangamo Therapeutics, Inc. | 149.07M | -1.60% | 2,804,255 | 32.88M |
| 332 | NKTX | Nkarta, Inc. | 148.45M | -0.95% | 704,433 | - |
| 333 | CDXS | Codexis, Inc. | 148.13M | -2.38% | 584,023 | 52.93M |
| 334 | CNTX | Context Therapeutics Inc. | 147.93M | 0.63% | 762,420 | - |
| 335 | SPRO | Spero Therapeutics, Inc. | 143.67M | -0.78% | 140,131 | 40.55M |
| 336 | ACTU | Actuate Therapeutics, Inc. | 142.71M | -2.23% | 70,748 | - |
| 337 | ACOG | Alpha Cognition Inc. | 141.98M | -0.46% | 56,847 | 7.43M |
| 338 | MCRB | Seres Therapeutics, Inc. | 141.58M | 1.29% | 22,748 | 351.00K |
| 339 | ELTX | Elicio Therapeutics, Inc. | 140.85M | -2.18% | 143,537 | - |
| 340 | ELDN | Eledon Pharmaceuticals, Inc. | 137.28M | - | 681,747 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 136.52M | -1.44% | 237,415 | 2.00M |
| 342 | TTRX | Turn Therapeutics Inc. | 136.04M | -0.65% | 14,592 | - |
| 343 | FBIO | Fortress Biotech, Inc. | 133.46M | -1.83% | 914,879 | 62.30M |
| 344 | IRD | Opus Genetics, Inc. | 133.10M | -3.50% | 605,767 | 14.63M |
| 345 | AGEN | Agenus Inc. | 132.97M | 4.27% | 671,105 | 106.83M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 132.82M | 0.98% | 379,017 | - |
| 347 | VRCA | Verrica Pharmaceuticals Inc. | 127.04M | -0.94% | 156,156 | 30.83M |
| 348 | HYFT | MindWalk Holdings Corp. | 127.00M | -2.16% | 595,271 | 19.02M |
| 349 | CGTX | Cognition Therapeutics, Inc. | 124.47M | -1.40% | 452,068 | - |
| 350 | WHWK | Whitehawk Therapeutics, Inc. | 124.42M | -2.58% | 75,868 | 14.38M |
| 351 | FATE | Fate Therapeutics, Inc. | 121.12M | -0.94% | 1,242,991 | 7.14M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 120.19M | -3.59% | 37,790 | 762.00K |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 119.17M | 6.00% | 242,687 | 251.00K |
| 354 | MGNX | MacroGenics, Inc. | 115.76M | 2.23% | 1,044,449 | 127.63M |
| 355 | ANIX | Anixa Biosciences, Inc. | 111.26M | -1.17% | 449,819 | - |
| 356 | SEER | Seer, Inc. | 109.69M | 4.28% | 263,492 | 16.38M |
| 357 | ABOS | Acumen Pharmaceuticals, Inc. | 109.64M | -2.69% | 279,617 | - |
| 358 | PYXS | Pyxis Oncology, Inc. | 109.59M | 21.38% | 2,912,972 | 2.82M |
| 359 | RPTX | Repare Therapeutics Inc. | 109.50M | 0.40% | 814,450 | 11.87M |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 107.18M | -3.11% | 1,696,661 | 182.34K |
| 361 | GNLX | Genelux Corporation | 105.33M | 2.94% | 810,224 | 8.00K |
| 362 | STRO | Sutro Biopharma, Inc. | 104.19M | 4.09% | 203,742 | 105.65M |
| 363 | ONCY | Oncolytics Biotech Inc. | 104.13M | -2.41% | 646,313 | - |
| 364 | OKYO | OKYO Pharma Limited | 103.81M | 18.97% | 762,867 | - |
| 365 | CBUS | Cibus, Inc. | 102.05M | -8.29% | 391,127 | 3.79M |
| 366 | THAR | Tharimmune, Inc. | 101.68M | -4.12% | 340,934 | - |
| 367 | COYA | Coya Therapeutics, Inc. | 101.48M | -5.27% | 572,688 | 3.99M |
| 368 | SAVA | Cassava Sciences, Inc. | 101.45M | -1.87% | 551,175 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 100.40M | 5.97% | 1,452,657 | - |
| 370 | ATRA | Atara Biotherapeutics, Inc. | 98.56M | -21.62% | 843,003 | 151.93M |
| 371 | ANVS | Annovis Bio, Inc. | 97.27M | -6.38% | 394,829 | - |
| 372 | VANI | Vivani Medical, Inc. | 97.03M | 1.53% | 78,694 | - |
| 373 | DTIL | Precision BioSciences, Inc. | 94.36M | -2.73% | 273,605 | 698.00K |
| 374 | CSBR | Champions Oncology, Inc. | 94.15M | -0.15% | 5,246 | 58.42M |
| 375 | ETHZ | ETHZilla Corporation | 90.88M | -2.05% | 468,849 | 4.11M |
| 376 | KRRO | Korro Bio, Inc. | 89.46M | 3.83% | 262,730 | 7.37M |
| 377 | GANX | Gain Therapeutics, Inc. | 88.85M | -5.33% | 1,121,431 | - |
| 378 | SPRB | Spruce Biosciences, Inc. | 85.62M | 8.53% | 32,087 | 697.00K |
| 379 | DWTX | Dogwood Therapeutics, Inc. | 84.72M | -9.52% | 132,589 | - |
| 380 | CALC | CalciMedica, Inc. | 84.30M | 9.76% | 101,036 | - |
| 381 | ATOS | Atossa Therapeutics, Inc. | 83.33M | -1.21% | 887,183 | - |
| 382 | ACET | Adicet Bio, Inc. | 81.15M | -0.74% | 138,371 | - |
| 383 | PLRX | Pliant Therapeutics, Inc. | 81.11M | 0.76% | 1,399,719 | - |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.00M | -2.99% | 38,948 | 501.00K |
| 385 | EXOZ | eXoZymes, Inc. | 80.94M | -0.31% | 3,373 | -700.00 |
| 386 | PTHS | Pelthos Therapeutics Inc. | 80.02M | -7.61% | 27,578 | 7.41M |
| 387 | IMUX | Immunic, Inc. | 79.98M | 0.33% | 1,737,726 | - |
| 388 | MREO | Mereo BioPharma Group plc | 78.67M | 28.62% | 44,756,230 | 500.00K |
| 389 | XBIT | XBiotech Inc. | 78.05M | -3.02% | 37,096 | - |
| 390 | TVGN | Tevogen Bio Holdings Inc. | 77.29M | -0.26% | 2,094,051 | - |
| 391 | PYPD | PolyPid Ltd. | 77.19M | -0.22% | 35,843 | - |
| 392 | PSTV | Plus Therapeutics, Inc. | 76.30M | -5.11% | 6,838,520 | 5.26M |
| 393 | MNOV | MediciNova, Inc. | 74.70M | 7.04% | 73,813 | 257.92K |
| 394 | KZIA | Kazia Therapeutics Limited | 74.31M | 0.59% | 240,395 | 1.20M |
| 395 | IMA | ImageneBio, Inc. | 73.92M | 2.48% | 14,196 | 800.00K |
| 396 | ENTX | Entera Bio Ltd. | 73.37M | -8.05% | 254,548 | 124.00K |
| 397 | ALXO | ALX Oncology Holdings Inc. | 73.19M | 8.87% | 275,303 | - |
| 398 | ADAG | Adagene Inc. | 72.11M | -7.27% | 60,812 | 103.20K |
| 399 | CRVO | CervoMed Inc. | 71.57M | -1.72% | 60,496 | 6.16M |
| 400 | IFRX | InflaRx N.V. | 70.46M | -4.59% | 713,187 | 73.73K |
| 401 | ATYR | aTyr Pharma, Inc. | 69.84M | -1.71% | 1,818,169 | 190.00K |
| 402 | EQ | Equillium, Inc. | 69.42M | 0.88% | 346,368 | 4.39M |
| 403 | TCRX | TScan Therapeutics, Inc. | 68.67M | 2.54% | 777,216 | 8.42M |
| 404 | MGX | Metagenomi, Inc. | 67.21M | 1.13% | 256,892 | 30.91M |
| 405 | NRXP | NRx Pharmaceuticals, Inc. | 65.72M | -4.72% | 519,821 | 242.00K |
| 406 | BYSI | BeyondSpring Inc. | 65.38M | - | 28,771 | 1.88M |
| 407 | PASG | Passage Bio, Inc. | 63.10M | 8.29% | 168,484 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 62.79M | -0.84% | 216,999 | - |
| 409 | MAIA | MAIA Biotechnology, Inc. | 62.37M | -1.81% | 416,103 | - |
| 410 | IBIO | iBio, Inc. | 60.72M | 14.89% | 12,615,958 | 500.00K |
| 411 | RADX | Radiopharm Theranostics Limited | 59.17M | 7.52% | 134,652 | 8.20M |
| 412 | ANL | Adlai Nortye Ltd. | 59.04M | 8.84% | 90,336 | -1.35M |
| 413 | ICCC | ImmuCell Corporation | 58.75M | -1.14% | 19,760 | 27.77M |
| 414 | PDSB | PDS Biotechnology Corporation | 58.55M | 7.72% | 2,779,554 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 58.21M | - | 11,782 | - |
| 416 | ATHE | Alterity Therapeutics Limited | 58.10M | 5.71% | 15,256 | 3.57M |
| 417 | GRCE | Grace Therapeutics, Inc. | 57.10M | -2.89% | 211,971 | - |
| 418 | ALGS | Aligos Therapeutics, Inc. | 55.38M | -12.88% | 87,692 | 2.65M |
| 419 | ACRV | Acrivon Therapeutics, Inc. | 55.22M | -9.33% | 4,632,205 | - |
| 420 | OSTX | OS Therapies Incorporated | 54.58M | 0.65% | 854,629 | - |
| 421 | LITS | Lite Strategy, Inc. | 54.05M | -1.34% | 311,009 | - |
| 422 | NTRB | Nutriband Inc. | 53.12M | -1.13% | 21,046 | 2.28M |
| 423 | IBO | Impact BioMedical Inc. | 52.83M | -0.20% | 55,146 | 25.00K |
| 424 | NRXS | NeurAxis, Inc. | 51.77M | 4.97% | 229,372 | 3.36M |
| 425 | ABVC | ABVC BioPharma, Inc. | 51.38M | -3.11% | 65,280 | 797.92K |
| 426 | TIL | Instil Bio, Inc. | 48.36M | -3.52% | 258,112 | - |
| 427 | PTN | Palatin Technologies, Inc. | 47.18M | -8.87% | 32,208 | 8.85M |
| 428 | APLM | Apollomics, Inc. | 47.15M | -2.49% | 22,865 | 6.93M |
| 429 | NXTC | NextCure, Inc. | 46.87M | -1.62% | 48,585 | - |
| 430 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.84M | -4.20% | 39,491 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 46.76M | -4.23% | 268,281 | - |
| 432 | CVM | CEL-SCI Corporation | 46.08M | -6.48% | 56,812 | - |
| 433 | HURA | TuHURA Biosciences, Inc. | 45.77M | -0.11% | 315,531 | - |
| 434 | KZR | Kezar Life Sciences, Inc. | 45.40M | -4.62% | 112,556 | - |
| 435 | ESLA | Estrella Immunopharma, Inc. | 45.32M | -15.49% | 175,457 | - |
| 436 | LPCN | Lipocine Inc. | 44.47M | 6.37% | 77,582 | 4.32M |
| 437 | QTTB | Q32 Bio Inc. | 44.30M | 0.56% | 144,361 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 43.36M | -2.80% | 59,324 | 90.00K |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 42.69M | 7.57% | 301,893 | - |
| 440 | OKUR | OnKure Therapeutics, Inc. | 42.54M | 9.79% | 260,428 | - |
| 441 | EVAX | Evaxion A/S | 42.37M | -0.59% | 20,300 | 7.65M |
| 442 | JSPR | Jasper Therapeutics, Inc. | 42.26M | -9.04% | 2,570,513 | - |
| 443 | RNXT | RenovoRx, Inc. | 41.05M | -2.61% | 892,514 | 928.00K |
| 444 | IOBT | IO Biotech, Inc. | 40.46M | 1.79% | 529,573 | - |
| 445 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.73M | -7.10% | 4,676,636 | - |
| 446 | INMB | INmune Bio, Inc. | 39.61M | -2.61% | 320,203 | 50.00K |
| 447 | LTRN | Lantern Pharma Inc. | 39.03M | 2.95% | 52,559 | - |
| 448 | VERU | Veru Inc. | 38.36M | 3.46% | 102,291 | 16.89M |
| 449 | OTLK | Outlook Therapeutics, Inc. | 37.83M | -2.37% | 4,308,592 | 1.41M |
| 450 | XCUR | Exicure, Inc. | 37.22M | -0.68% | 25,223 | 500.00K |
| 451 | CELU | Celularity Inc. | 37.02M | 3.17% | 20,749 | 40.58M |
| 452 | GBIO | Generation Bio Co. | 36.93M | -0.54% | 60,520 | 15.27M |
| 453 | JUNS | Jupiter Neurosciences, Inc. | 36.49M | 2.91% | 86,304 | - |
| 454 | XLO | Xilio Therapeutics, Inc. | 35.70M | -6.01% | 560,497 | 31.80M |
| 455 | ANTX | AN2 Therapeutics, Inc. | 35.62M | -1.52% | 71,555 | - |
| 456 | DYAI | Dyadic International, Inc. | 34.38M | -1.88% | 39,564 | 3.34M |
| 457 | MRKR | Marker Therapeutics, Inc. | 33.35M | -3.38% | 560,485 | 4.69M |
| 458 | GNTA | Genenta Science S.p.A. | 33.27M | -1.39% | 73,548 | - |
| 459 | CING | Cingulate Inc. | 33.26M | -8.86% | 436,012 | - |
| 460 | CUE | Cue Biopharma, Inc. | 32.89M | -8.25% | 962,935 | 7.10M |
| 461 | GLTO | Galecto, Inc. | 32.70M | 0.64% | 13,564 | - |
| 462 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.80M | -2.67% | 70,888 | - |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 31.78M | 14.07% | 447,061 | - |
| 464 | SKYE | Skye Bioscience, Inc. | 31.42M | -6.67% | 323,817 | - |
| 465 | BRNS | Barinthus Biotherapeutics plc | 31.01M | 0.21% | 18,391 | 14.97M |
| 466 | RNTX | Rein Therapeutics Inc. | 30.76M | -4.10% | 144,521 | - |
| 467 | RLYB | Rallybio Corporation | 30.00M | -3.78% | 42,293 | 674.00K |
| 468 | BOLD | Boundless Bio, Inc. | 29.32M | - | 97,844 | - |
| 469 | HOWL | Werewolf Therapeutics, Inc. | 29.29M | -4.25% | 451,308 | 1.14M |
| 470 | SNTI | Senti Biosciences, Inc. | 29.18M | 2.78% | 268,389 | - |
| 471 | IGC | IGC Pharma, Inc. | 28.77M | -1.54% | 220,509 | 1.11M |
| 472 | DARE | Daré Bioscience, Inc. | 28.29M | -4.35% | 27,043 | -57.13K |
| 473 | PLUR | Pluri Inc. | 28.14M | 1.33% | 4,676 | 1.33M |
| 474 | SER | Serina Therapeutics, Inc. | 27.09M | -3.05% | 66,738 | 116.00K |
| 475 | QNTM | Quantum BioPharma Ltd. | 27.04M | -4.55% | 39,813 | - |
| 476 | HYPD | Hyperion DeFi, Inc. | 26.97M | -4.35% | 186,289 | 345.32K |
| 477 | ATHA | Athira Pharma, Inc. | 26.62M | -6.12% | 70,253 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 26.07M | -6.21% | 1,715,324 | 721.00K |
| 479 | PLRZ | Polyrizon Ltd. | 25.24M | -4.62% | 43,806 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 24.96M | -4.28% | 675,239 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 24.52M | -1.26% | 318,808 | - |
| 482 | NNVC | NanoViricides, Inc. | 24.16M | -7.44% | 367,505 | - |
| 483 | CASI | CASI Pharmaceuticals, Inc. | 22.60M | 3.29% | 115,841 | 26.85M |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 22.53M | 2.95% | 63,319 | 15.65M |
| 485 | LNAI | Lunai Bioworks Inc. | 22.49M | 5.47% | 127,019 | - |
| 486 | FBLG | FibroBiologics, Inc. | 22.48M | 2.42% | 896,365 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.50M | 1.12% | 116,589 | - |
| 488 | BCAB | BioAtla, Inc. | 21.26M | -10.08% | 1,748,916 | 11.00M |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.32M | -1.68% | 73,689 | - |
| 490 | LIMN | Liminatus Pharma, Inc. | 19.65M | -11.46% | 200,620 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 19.10M | 3.68% | 71,465 | - |
| 492 | VYNE | VYNE Therapeutics Inc. | 18.96M | 0.11% | 403,165 | 524.00K |
| 493 | CLGN | CollPlant Biotechnologies Ltd. | 18.78M | 2.08% | 13,733 | 2.48M |
| 494 | LEXX | Lexaria Bioscience Corp. | 18.57M | 7.34% | 245,100 | 705.92K |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 18.43M | -1.37% | 276,738 | - |
| 496 | KAPA | Kairos Pharma, Ltd. | 18.32M | -9.28% | 148,702 | - |
| 497 | MTVA | MetaVia Inc. | 17.95M | -2.68% | 10,008 | - |
| 498 | PMN | ProMIS Neurosciences, Inc. | 17.50M | -4.13% | 4,678 | - |
| 499 | LSTA | Lisata Therapeutics, Inc. | 17.38M | -4.37% | 41,077 | 1.07M |
| 500 | ITRM | Iterum Therapeutics plc | 17.31M | -4.48% | 381,871 | 390.00K |
| 501 | OSRH | OSR Holdings, Inc. | 17.00M | 6.43% | 790,806 | -90.52K |
| 502 | HOTH | Hoth Therapeutics, Inc. | 16.76M | -1.82% | 82,854 | - |
| 503 | COCP | Cocrystal Pharma, Inc. | 15.71M | 3.64% | 150,490 | - |
| 504 | GRDX | GridAI Technologies Corp. | 15.70M | 3.32% | 144,850 | - |
| 505 | APLT | Applied Therapeutics, Inc. | 15.34M | 0.40% | 5,179,288 | 1.00M |
| 506 | GDTC | CytoMed Therapeutics Limited | 15.23M | 0.76% | 2,842 | 573.19K |
| 507 | BCDA | BioCardia, Inc. | 14.91M | 6.44% | 116,409 | 3.00K |
| 508 | KALA | KALA BIO, Inc. | 14.68M | -2.70% | 1,303,485 | - |
| 509 | SNSE | Sensei Biotherapeutics, Inc. | 14.65M | 5.02% | 32,423 | - |
| 510 | TPST | Tempest Therapeutics, Inc. | 14.24M | 0.35% | 36,937 | - |
| 511 | NCNA | NuCana plc | 14.03M | -6.39% | 65,057 | - |
| 512 | SNGX | Soligenix, Inc. | 13.62M | -6.25% | 147,855 | 2.34K |
| 513 | BCTX | BriaCell Therapeutics Corp. | 13.58M | -0.41% | 46,923 | - |
| 514 | SYBX | Synlogic, Inc. | 13.34M | -6.56% | 24,013 | 8.00K |
| 515 | LGVN | Longeveron Inc. | 13.30M | -0.91% | 238,923 | 1.44M |
| 516 | BLRX | BioLineRx Ltd. | 13.25M | -0.50% | 5,977 | 12.74M |
| 517 | CLRB | Cellectar Biosciences, Inc. | 13.06M | -6.95% | 99,053 | - |
| 518 | AKTX | Akari Therapeutics, Plc | 12.90M | -0.25% | 359,533 | - |
| 519 | AEON | AEON Biopharma, Inc. | 12.79M | -0.92% | 87,228 | - |
| 520 | IMNN | Imunon, Inc. | 12.55M | -4.40% | 41,939 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.50M | -0.66% | 11,966 | - |
| 522 | PHIO | Phio Pharmaceuticals Corp. | 12.49M | -2.52% | 139,362 | - |
| 523 | MBRX | Moleculin Biotech, Inc. | 12.26M | -3.16% | 113,695 | - |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 11.19M | 0.34% | 8,892 | 5.20M |
| 525 | ASBP | Aspire Biopharma Holdings, Inc. | 11.18M | 0.68% | 24,375,983 | 1.94K |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 11.02M | -0.56% | 59,725 | - |
| 527 | ABP | Abpro Holdings, Inc. | 10.97M | -0.49% | 7,932 | 183.00K |
| 528 | INAB | IN8bio, Inc. | 10.89M | -2.08% | 188,323 | - |
| 529 | TRAW | Traws Pharma, Inc. | 10.71M | -4.96% | 27,127 | 2.85M |
| 530 | CRIS | Curis, Inc. | 10.69M | -2.73% | 733,316 | 11.65M |
| 531 | BRTX | BioRestorative Therapies, Inc. | 10.61M | -0.42% | 9,119 | 383.40K |
| 532 | ERNA | Ernexa Therapeutics Inc. | 10.28M | -5.76% | 40,468 | 1,000.00 |
| 533 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.24M | -7.15% | 38,561 | - |
| 534 | NCEL | NewcelX Ltd. | 9.98M | -0.90% | 48,811 | - |
| 535 | EVGN | Evogene Ltd. | 9.90M | 0.45% | 26,856 | 8.02M |
| 536 | BIVI | BioVie Inc. | 9.57M | -2.31% | 44,561 | - |
| 537 | ALZN | Alzamend Neuro, Inc. | 9.09M | 2.14% | 83,282 | - |
| 538 | APVO | Aptevo Therapeutics Inc. | 9.04M | 5.00% | 6,276,819 | - |
| 539 | PMCB | PharmaCyte Biotech, Inc. | 8.93M | -4.28% | 206,506 | - |
| 540 | PULM | Pulmatrix, Inc. | 8.62M | 2.03% | 12,537 | 3.00K |
| 541 | APM | Aptorum Group Limited | 8.55M | -2.78% | 60,636 | - |
| 542 | MBIO | Mustang Bio, Inc. | 8.47M | 1.75% | 52,008 | - |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 8.42M | -0.86% | 35,542 | - |
| 544 | ICU | SeaStar Medical Holding Corporation | 8.15M | -6.22% | 103,770 | 881.00K |
| 545 | ADXN | Addex Therapeutics Ltd | 8.06M | - | 1,260 | 198.82K |
| 546 | KPRX | Kiora Pharmaceuticals, Inc. | 7.89M | -1.60% | 97,834 | 20.00K |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 7.86M | -8.16% | 130,710 | 6.00K |
| 548 | IMRN | Immuron Limited | 7.84M | 3.94% | 17,841 | 4.78M |
| 549 | PCSA | Processa Pharmaceuticals, Inc. | 7.61M | -2.89% | 126,733 | - |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 7.34M | 1.01% | 23,646 | - |
| 551 | TOVX | Theriva Biologics, Inc. | 7.25M | -2.10% | 1,315,665 | - |
| 552 | GTBP | GT Biopharma, Inc. | 7.20M | -0.44% | 1,585,416 | - |
| 553 | GOVX | GeoVax Labs, Inc. | 7.11M | -10.39% | 4,802,153 | 3.35M |
| 554 | PPBT | Purple Biotech Ltd | 7.07M | -2.57% | 78,649 | - |
| 555 | TCRT | Alaunos Therapeutics, Inc. | 7.03M | -11.02% | 50,874 | 6.00K |
| 556 | ACXP | Acurx Pharmaceuticals, Inc. | 6.88M | 0.34% | 20,102 | - |
| 557 | BGMS | Bio Green Med Solution, Inc. | 6.71M | 0.74% | 19,455 | 81.00K |
| 558 | LYRA | Lyra Therapeutics, Inc. | 6.69M | -0.87% | 12,343 | 600.00K |
| 559 | SLXN | Silexion Therapeutics Corp | 6.63M | 0.95% | 22,344 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 6.61M | 0.54% | 80,475 | 488.24K |
| 561 | XTLB | XTL Biopharmaceuticals Ltd. | 6.60M | -2.52% | 37,239 | 968.00K |
| 562 | ADIL | Adial Pharmaceuticals, Inc. | 6.45M | 3.64% | 257,218 | - |
| 563 | CYCN | Cyclerion Therapeutics, Inc. | 6.28M | -14.51% | 528,242 | 2.86M |
| 564 | PPCB | Propanc Biopharma, Inc. | 6.18M | -3.79% | 89,746 | - |
| 565 | CANF | Can-Fite BioPharma Ltd. | 5.67M | -5.05% | 38,867 | 560.00K |
| 566 | INDP | Indaptus Therapeutics, Inc. | 5.48M | 4.33% | 175,250 | - |
| 567 | REVB | Revelation Biosciences, Inc. | 5.33M | -0.02% | 113,689 | - |
| 568 | DCOY | Decoy Therapeutics Inc. | 5.23M | 6.47% | 301,253 | - |
| 569 | SILO | Silo Pharma, Inc. | 5.23M | 0.93% | 43,170 | 72.10K |
| 570 | GNPX | Genprex, Inc. | 5.10M | 10.00% | 3,251,180 | - |
| 571 | XBIO | Xenetic Biosciences, Inc. | 5.05M | 0.96% | 7,575 | 2.86M |
| 572 | VIVS | VivoSim Labs, Inc. | 5.01M | -7.69% | 54,505 | 140.00K |
| 573 | SPRC | SciSparc Ltd. | 4.78M | -3.31% | 90,991 | 1.31M |
| 574 | JAGX | Jaguar Health, Inc. | 4.76M | -2.78% | 179,386 | 11.79M |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 4.56M | -1.99% | 45,640 | - |
| 576 | MTNB | Matinas BioPharma Holdings, Inc. | 4.12M | -11.29% | 24,366 | - |
| 577 | ENVB | Enveric Biosciences, Inc. | 4.05M | -2.94% | 21,282 | - |
| 578 | XRTX | XORTX Therapeutics Inc. | 4.01M | -0.85% | 7,935 | - |
| 579 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.74M | -14.58% | 447,451 | 15.78K |
| 580 | ENSC | Ensysce Biosciences, Inc. | 3.70M | -3.77% | 94,789 | 4.49M |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 3.61M | -2.02% | 17,217 | - |
| 582 | CMND | Clearmind Medicine Inc. | 3.52M | -3.29% | 41,182 | - |
| 583 | PHGE | BiomX Inc. | 3.48M | 1.79% | 59,799 | - |
| 584 | OGEN | Oragenics, Inc. | 3.46M | -2.22% | 47,442 | - |
| 585 | HCWB | HCW Biologics Inc. | 3.30M | - | 41,765 | 422.03K |
| 586 | AZTR | Azitra, Inc. | 3.11M | -4.57% | 458,355 | 7.50K |
| 587 | BBLG | Bone Biologics Corporation | 2.91M | 4.52% | 38,944 | - |
| 588 | ARTL | Artelo Biosciences, Inc. | 2.87M | -11.25% | 110,601 | - |
| 589 | VRAX | Virax Biolabs Group Limited | 2.69M | -1.63% | 71,277 | 2.99K |
| 590 | ONCO | Onconetix, Inc. | 2.67M | - | 104,268 | 1.22M |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.64M | -5.74% | 19,441 | 1.15M |
| 592 | CDT | CDT Equity Inc. | 2.62M | -1.31% | 19,329 | - |
| 593 | DRMA | Dermata Therapeutics, Inc. | 2.45M | -2.80% | 59,866 | - |
| 594 | GRI | GRI Bio, Inc. | 2.28M | -20.77% | 5,134,317 | - |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.23M | 2.71% | 156,915 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.97M | 1.73% | 121,049 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.50M | 4.14% | 306,278 | - |
| 598 | ADTX | Aditxt, Inc. | 1.40M | -5.49% | 292,494 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.13M | -5.82% | 11,749 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 976.66K | -5.75% | 515,815 | 285.95K |